Kondo A, Oketani N, Maruyama M, Taguchi Y, Yamaguchi Y, Miyao H, Mashima I, Oono M, Wada K, Tsuchiya T, Takahashi H, Abe S
Department of Respiratory Medicine, National Sanatorium Nishi-Niigata-Chuo-Byoin, Japan.
Kekkaku. 1998 Oct;73(10):585-90.
Elevated levels of serum surfactant protein-D (SP-D) have been previously reported in patients with idiopathic pulmonary fibrosis (IPF) and pulmonary alveolar proteinosis. To determine whether the same change is seen in other pulmonary diseases, especially pulmonary tuberculosis (TB), we measured the serum SP-D levels in active pulmonary TB (smear and/or culture: positive), acute interstitial pneumonia (AIP), IPF, acute exacerbation of IPF, hypersensitivity pneumonitis (HP), pneumoconiosis, bronchiectasis, and bacterial pneumonia by an enzyme-linked immunosorbent assay using monoclonal antibodies to human lung SP-D, and compared them with those of healthy elderly subjects over 50 years of age. The SP-D level in the healthy elderly subjects was 57.6 +/- 38.4 ng/ml (mean +/- SD, n = 287). The levels in patients with active pulmonary TB (140.6 +/- 18.2 ng/ml, n = 49), AIP (1,021 ng/ml, n = 1), IPF (307.0 +/- 180.7 ng/ml, n = 42), acute exacerbation of IPF (817.7 +/- 283.6 ng/ml, n = 3), and HP (716.6 +/- 548.8 ng/ml, n = 4) were significantly higher than those in the healthy elderly controls (p < 0.05), whereas those of pneumoconiosis, bronchiectasis, and bacterial pneumonia, 121.9 +/- 92.8 ng/ml (n = 8), 93.9 +/- 72.9 ng/ml (n = 11), and 72.7 +/- 3.4 ng/ml (n = 4), respectively, showed no significant difference with the controls. In active pulmonary TB, the percentage of patients whose serum SP-D levels were over 134.6 ng/ml (mean + 2SD of healthy elderly controls) was 34.7%, and therefore we considered the serum SP-D level was not useful for the diagnosis of pulmonary TB. However, it was significantly higher in the patients with cavity formation than in those without (p < 0.05), and there was a significant positive correlation between the serum SP-D level and the number of tubercle bacilli in the sputum (r = 0.416, p = 0.00165), erythrocyte sedimentation rate at 1 hr (r = 0.489, p < 0.01), and CRP level (r = 0.383, p = 0.003). These findings suggest that the serum SP-D level is a useful indicator of the disease activity in pulmonary TB.
先前已有报道称,特发性肺纤维化(IPF)和肺泡蛋白沉积症患者的血清表面活性蛋白-D(SP-D)水平升高。为了确定其他肺部疾病,尤其是肺结核(TB)患者是否也有同样的变化,我们采用针对人肺SP-D的单克隆抗体,通过酶联免疫吸附测定法,测量了活动性肺结核(涂片和/或培养:阳性)、急性间质性肺炎(AIP)、IPF、IPF急性加重期、过敏性肺炎(HP)、尘肺、支气管扩张和细菌性肺炎患者的血清SP-D水平,并将其与50岁以上健康老年人的水平进行比较。健康老年人的SP-D水平为57.6±38.4 ng/ml(平均值±标准差,n = 287)。活动性肺结核患者(140.6±18.2 ng/ml,n = 49)、AIP患者(1021 ng/ml,n = 1)、IPF患者(307.0±180.7 ng/ml,n = 42)、IPF急性加重期患者(817.7±283.6 ng/ml,n = 3)和HP患者(716.6±548.8 ng/ml,n = 4)的水平显著高于健康老年对照组(p < 0.05),而尘肺、支气管扩张和细菌性肺炎患者的水平分别为121.9±92.8 ng/ml(n = 8)、93.9±72.9 ng/ml(n = 11)和72.7±3.4 ng/ml(n = 4),与对照组无显著差异。在活动性肺结核患者中,血清SP-D水平超过134.6 ng/ml(健康老年对照组平均值 + 2标准差)的患者比例为34.7%,因此我们认为血清SP-D水平对肺结核的诊断没有帮助。然而,有空洞形成的患者血清SP-D水平显著高于无空洞形成的患者(p < 0.05),血清SP-D水平与痰中结核杆菌数量(r = 0.416,p = 0.00165)、1小时红细胞沉降率(r = 0.489,p < 0.01)和CRP水平(r = 0.383,p = 0.003)之间存在显著正相关。这些发现表明,血清SP-D水平是肺结核疾病活动的有用指标。